🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Biliary Track Cancer

Histotripsy in Biliary Tract Cancer NCT07853690NA1 site📍 New York NYU Langone Health · Tests: Gemcitabine, Cisplatin, Durvalumab, Pembrolizumab, Histotripsy A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening NCT07176962n/a1 site📍 Shanghai Yingbin Liu, MD, PhD, FACS Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers NCT06001658Phase 21 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Gemcitabine, Cisplatin, Pembrolizumab Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study NCT04935853n/a32 sites📍 Amiens📍 Angers📍 Besançon GERCOR - Multidisciplinary Oncology Cooperative Group
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy